Skip to main content
    V

    Viridian Therapeutics Inc (VRDN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $29.80
    -1.07 (-3.47%)

    Market Cap: $3.51B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Viridian Therapeutics Inc (VRDN) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Viridian Therapeutics are Viking Therapeutics (VKTX), Beam Therapeutics (BEAM) and Vir Biotechnology (VIR). By market cap, Viridian Therapeutics ranks 6th of the 13 companies on this page; Edgewise Therapeutics (EWTX) is the largest at $5.03B.

    Peer Comparison

    VRDN's ROIC of -41.8% is above the peer median of -45.4%, and its revenue growth of -63.5% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Viridian Therapeutics (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Viking Therapeutics Inc (VKTX)$3.73BN/AN/A0.0%-61.0%0.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Travere Therapeutics Inc (TVTX)$4.86BN/A7.2x-18.7%-23.1%36.2%0.00%
    Vera Therapeutics Inc (VERA)$2.03BN/A189.3x0.0%-83.0%0.0%0.00%
    Vericel Corp Ord (VCEL)$2.91B89.8x9.1x10.3%N/A26.5%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Pharvaris BV (PHVS)$2.36BN/AN/A0.0%N/A0.0%0.00%
    Iovance Biotherapeutics Inc (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Edgewise Therapeutics Inc (EWTX)$5.03BN/AN/A0.0%N/A0.0%0.00%
    Trevi Therapeutics Inc (TRVI)$1.95BN/AN/A0.0%N/A0.0%0.00%
    Enliven Therapeutics Inc. (ELVN)$3.59BN/AN/A0.0%N/A0.0%0.00%
    Peer median$3.15B178.2x9.1x0.0%-45.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Viridian Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Viking Therapeutics Inc (VKTX)
    Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders.
    VKTX competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Travere Therapeutics Inc (TVTX)
    Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification...
    TVTX competitors
    Vera Therapeutics Inc (VERA)
    Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases...
    VERA competitors
    Vericel Corp Ord (VCEL)
    Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures...
    VCEL competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Pharvaris BV (PHVS)
    Pharvaris NV, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies.
    PHVS competitors
    Iovance Biotherapeutics Inc (IOVA)
    Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness...
    IOVA competitors
    Edgewise Therapeutics Inc (EWTX)
    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases.
    EWTX competitors
    Trevi Therapeutics Inc (TRVI)
    Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the development and commercialization of Haduvio to treat serious...
    TRVI competitors
    Enliven Therapeutics Inc. (ELVN)
    Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare...
    ELVN competitors

    Frequently Asked Questions About VRDN

    Who are Viridian Therapeutics' main competitors?

    The companies most similar to Viridian Therapeutics include Viking Therapeutics (VKTX), Beam Therapeutics (BEAM), Vir Biotechnology (VIR), Travere Therapeutics (TVTX) and Vera Therapeutics (VERA), listed from the closest match.

    Who is Viridian Therapeutics' biggest competitor?

    Edgewise Therapeutics (EWTX) is the largest of the similar companies at $5.03B; Viking Therapeutics (VKTX) is the closest match by business profile, size, sector and industry.

    How does VRDN stock compare with its competitors?

    VRDN's P/S is 128.5x against a peer median of 9.1x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Viridian Therapeutics' competitors pays a higher dividend?

    Viridian Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Viridian Therapeutics bigger than its competitors?

    No. Viridian Therapeutics is 6th by market cap among the 13 companies on this page; the largest is Edgewise Therapeutics (EWTX) at $5.03B.